Reports >
Life Sciences
>
Biobanking Market Report
Biobanking Market Report
First published: 10 October 2024 | Last updated: 25 May 2026 | Report Code: biobanking
Biobanking Market — USD 10 billion in 2023, Growing to USD 17.29B by 2033 at 5.5% CAGR
This report provides an in-depth analysis of the global biobanking market, encompassing trends, forecasts, and insights tailored for the period from 2023 to 2033. It highlights critical data points, regional dynamics, and industry analysis essential for stakeholders in the biobanking sector.
Key Takeaways
- Global market value increases from $10.00 Billion in 2023 to $17.29 Billion in 2033, reflecting a 5.5% CAGR across 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, growing from $3.63 Billion in 2023 to $6.28 Billion in 2033.
- Europe expands from $3.25 Billion in 2023 to $5.62 Billion in 2033, driven by research infrastructure and regulatory frameworks.
- Asia Pacific rises from $1.85 Billion in 2023 to $3.2 Billion in 2033 amid expanding clinical research and biobanking services.
- Top firms featured include BD Biosciences, Thermo Fisher Scientific, Qiagen, Eppendorf AG, and VWR International LLC.
Biobanking Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The biobanking sector is projected to grow from $10.00 Billion in 2023 to $17.29 Billion in 2033, at a 5.5% CAGR over the 2023 to 2033 forecast period. Growth is supported by rising demand for preserved biological samples, advancements in sample storage and analysis technologies, and greater emphasis on personalized medicine and therapeutic research. Investments in automated biobanking, bioinformatics, and stricter consent and ethical requirements are reshaping operational models. Major life-sciences suppliers such as BD Biosciences, Thermo Fisher Scientific, Qiagen, Eppendorf AG, and VWR International LLC play active roles in supplying instrumentation, storage solutions, and data management platforms. The market structure comprises sample collection, storage, analysis technologies, data management solutions, and a diverse end-user base including hospitals, academic institutions, pharmaceutical and biotechnology companies.
Key Growth Drivers
- Rising research funding and clinical trial activity increasing demand for preserved biological samples.
- Technological improvements in sample preservation and automated storage enhancing operational efficiency.
- Expanding emphasis on personalized medicine and therapeutic research fueling need for diverse biorepositories.
- Greater adoption of bioinformatics and data management solutions to handle growing sample and data volumes.
- Regulatory focus on ethical sourcing and consent prompting investment in compliant storage and tracking systems.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $10.00 Billion |
| CAGR (2023-2033) | 5.5% |
| 2033 Market Size | $17.29 Billion |
| Top Companies | BD Biosciences, Thermo Fisher Scientific, Qiagen , Eppendorf AG, VWR International LLC |
| Published Date | 10 October 2024 |
| Last Modified Date | 25 May 2026 |
Biobanking Market Overview
Customize Biobanking Market Report market research report
- ✔ Get in-depth analysis of Biobanking market size, growth, and forecasts.
- ✔ Understand Biobanking's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biobanking
What is the Market Size & CAGR of Biobanking Market Report market in 2023?
Biobanking Industry Analysis
Biobanking Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biobanking Market Report Market Analysis Report by Region
Europe Biobanking Market Report:
Europe grows from $3.25 Billion in 2023 to $5.62 Billion in 2033. Local drivers include strong academic and clinical research activity, regulatory emphasis on ethical sourcing, and investments in sample preservation technologies.Asia Pacific Biobanking Market Report:
Asia Pacific grows from $1.85 Billion in 2023 to $3.2 Billion in 2033. Growth is supported by expanding clinical research, rising biotechnology activity, and increasing adoption of biobanking services and data-driven sample management.North America Biobanking Market Report:
North America is largest regional market, rising from $3.63 Billion in 2023 to $6.28 Billion in 2033. The region's scale reflects established research networks, investment in clinical trials, and demand for advanced storage and data management solutions.South America Biobanking Market Report:
Latin America grows from $0.6 Billion in 2023 to $1.03 Billion in 2033. Regional expansion is associated with growing research collaborations, rising demand for sample repositories, and incremental investments in storage infrastructure.Middle East & Africa Biobanking Market Report:
Middle East and Africa grows from $0.67 Billion in 2023 to $1.16 Billion in 2033. Drivers include developing research capacity, increased focus on local biobanking capabilities, and partnerships that support sample collection and storage.Tell us your focus area and get a customized research report.
Research Methodology
Biobanking Market Analysis By Biomaterial
In terms of biomaterials, the biobanking market is significantly driven by blood samples, which accounted for $6.52 billion in 2023 and is forecasted to grow to $11.28 billion by 2033. Tissue samples and organ samples also play pivotal roles, with tissue samples generating $2.20 billion in 2023 and expected to reach $3.80 billion by 2033, while organ samples projected to grow from $1.28 billion to $2.22 billion in the same timeframe.
Biobanking Market Analysis By Application
The research application in the biobanking market is prominent, valued at approximately $6.52 billion in 2023 and projected to reach $11.28 billion by 2033. Diagnostics and therapeutics follow suit, with diagnostics starting at $2.20 billion and expected to rise to $3.80 billion, while therapeutics will grow from $1.28 billion to $2.22 billion during the same period.
Biobanking Market Analysis By Storage Type
Preferring frozen storage technology, the market is estimated at $6.52 billion in 2023, projected to increase to $11.28 billion by 2033. Meanwhile, room temperature storage holds a market size of $2.20 billion and is expected to grow to $3.80 billion, emphasizing the varied methodologies of sample preservation available in biobanking.
Biobanking Market Analysis By End User
Hospitals dominate the biobanking market, representing a value of $5.42 billion in 2023 with a forecasted rise to $9.37 billion by 2033. Academic institutions and pharmaceutical companies hold significant shares too, contributing $2.13 billion and $1.38 billion in 2023, respectively. Their importance is underscored by their roles in research and therapeutic developments.
Biobanking Market Analysis By Region
Technology-driven analysis indicates that sample collection technologies command a substantial share of the market, valued at $5.42 billion in 2023, projected to reach $9.37 billion by 2033. Data management solutions are also pivotal, growing from $1.07 billion to $1.86 billion, reflecting the technological advancements in biobanking.
Biobanking Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biobanking Industry
BD Biosciences:
A leader in the development of innovative technologies for the collection and preparation of biological samples, BD Biosciences provides solutions that enhance the efficiency of biobanks globally.Thermo Fisher Scientific:
Known for its extensive portfolio of biobank reagents and equipment, Thermo Fisher Scientific is at the forefront of biobanking technology, enabling researchers to accelerate their studies.Qiagen :
Qiagen specializes in sample and assay technologies, providing integrated solutions that are essential for biobanking, including sample preparation and management tools.Eppendorf AG:
Eppendorf is renowned for its laboratory equipment and accessories, including solutions that support the cooling and preservation of biological samples in biobanks.VWR International LLC:
A global leader in laboratory supplies and equipment, VWR offers a broad range of products and services tailored for the needs of biobanks and their operations.We're grateful to work with incredible clients.
FAQs
What is the market size of the biobanking market in 2023?
The market size in 2023 is $10.00 Billion, according to the reported market figures for the 2023 baseline year.
How big is the biobanking market expected to be in 2033?
The biobanking market is projected to reach $17.29 Billion by 2033 based on the provided forecast for the 2023 to 2033 period.
What is CAGR for the biobanking market over the forecast period?
The reported compound annual growth rate (CAGR) for the 2023 to 2033 forecast period is 5.5%.
Is there a single fastest Growing region in the Biobanking Market Report market?
No single fastest-growing region is stated for the Biobanking Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are highlighted in the report?
Top companies listed include BD Biosciences, Thermo Fisher Scientific, Qiagen, Eppendorf AG, and VWR International LLC.
What are common end users of biobanking services?
Reported end users include hospitals, academic institutions, pharmaceutical companies, and biotechnology companies as primary consumers of biobanking solutions.
What are the primary application areas for biobanking?
The main applications cited are research, diagnostics, and therapeutics, reflecting diverse uses of stored biological materials.
How are sample types categorized in the market segmentation?
Biomaterials are categorized by blood samples, tissue samples, and organ samples as listed subsegments within the study.
What storage types are covered in the report?
Storage-type subsegments include frozen storage, room temperature storage, and controlled temperature storage, per the segmentation details.
Why is data management important in biobanking?
Data management solutions are crucial for tracking samples, ensuring traceability, and supporting bioinformatics needs arising from large-scale sample collections.